Crossmark

The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment

Crossref DOI link: https://doi.org/10.1007/s11019-022-10106-y

Published Online: 2022-08-11

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hordijk, Marjolijn

Vermeulen, Stefan F. https://orcid.org/0000-0002-8797-9172
Bunnik, Eline M. https://orcid.org/0000-0003-1481-6222
License Information

Text and Data Mining valid from 2022-08-11

Version of Record valid from 2022-08-11
More Information

Article History

Received: 5 April 2022

Revised: 27 June 2022

Accepted: 7 July 2022

First Online: 11 August 2022